MASP1 and myeloid sarcoma: The p.Gly459Asp substitution identified in MS patients is located exclusively in the serine protease domain of isoform 2, also known as MASP3, is highly conserved in orthologs and most paralogs (Fig 4), and is predicted damaging for protein function (CADD = 26.2).